文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

营养限制激活的 Fra-2 通过 miR-15a 下调的 IGF1R 促进胰腺导管腺癌的肿瘤进展。

Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.

机构信息

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, 43210, OH, USA.

Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sant'Andrea Hospital, University of Rome "Sapienza", Rome, 00189, Italy.

出版信息

Signal Transduct Target Ther. 2024 Feb 12;9(1):31. doi: 10.1038/s41392-024-01740-4.


DOI:10.1038/s41392-024-01740-4
PMID:38342897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10859382/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, characterized by an intense desmoplastic reaction that compresses blood vessels and limits nutrient supplies. PDAC aggressiveness largely relies on its extraordinary capability to thrive and progress in a challenging tumor microenvironment. Dysregulation of the onco-suppressor miR-15a has been extensively documented in PDAC. Here, we identified the transcription factor Fos-related antigen-2 (Fra-2) as a miR-15a target mediating the adaptive mechanism of PDAC to nutrient deprivation. We report that the IGF1 signaling pathway was enhanced in nutrient deprived PDAC cells and that Fra-2 and IGF1R were significantly overexpressed in miR-15a downmodulated PDAC patients. Mechanistically, we discovered that miR-15a repressed IGF1R expression via Fra-2 targeting. In miR-15a-low context, IGF1R hyperactivated mTOR, modulated the autophagic flux and sustained PDAC growth in nutrient deprivation. In a genetic mouse model, Mir15a PDAC showed Fra-2 and Igf1r upregulation and mTOR activation in response to diet restriction. Consistently, nutrient restriction improved the efficacy of IGF1R inhibition in a Fra-2 dependent manner. Overall, our results point to a crucial role of Fra-2 in the cellular stress response due to nutrient restriction typical of pancreatic cancer and support IGF1R as a promising and vulnerable target in miR-15a downmodulated PDAC.

摘要

胰腺导管腺癌 (PDAC) 是一种致命性疾病,其特征为强烈的促结缔组织反应,这种反应会压迫血管并限制营养供应。PDAC 的侵袭性在很大程度上依赖于其在极具挑战性的肿瘤微环境中茁壮成长和发展的非凡能力。miR-15a 的致癌抑制因子失调在 PDAC 中已得到广泛证实。在这里,我们鉴定出转录因子 Fos 相关抗原-2 (Fra-2) 是 miR-15a 的靶标,介导 PDAC 对营养缺乏的适应性机制。我们报告说,在营养剥夺的 PDAC 细胞中 IGF1 信号通路增强,并且 Fra-2 和 IGF1R 在 miR-15a 下调的 PDAC 患者中显著过表达。从机制上讲,我们发现 miR-15a 通过靶向 Fra-2 抑制 IGF1R 的表达。在 miR-15a 低表达的情况下,IGF1R 过度激活 mTOR,调节自噬通量,并在营养缺乏时维持 PDAC 的生长。在遗传小鼠模型中,Mir15a PDAC 表现出 Fra-2 和 Igf1r 的上调以及 mTOR 的激活,以响应饮食限制。一致地,营养限制以 Fra-2 依赖的方式提高了 IGF1R 抑制的疗效。总的来说,我们的结果表明 Fra-2 在由于营养限制而导致的细胞应激反应中起着关键作用,这是典型的胰腺癌特征,并支持 IGF1R 作为 miR-15a 下调的 PDAC 中一个有前途且脆弱的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/933b3173f8af/41392_2024_1740_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/425ed53c9148/41392_2024_1740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/d25ffa0f80ba/41392_2024_1740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/5ac0818575ba/41392_2024_1740_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/9bf724f837b1/41392_2024_1740_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/b2750261e556/41392_2024_1740_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/933b3173f8af/41392_2024_1740_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/425ed53c9148/41392_2024_1740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/d25ffa0f80ba/41392_2024_1740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/5ac0818575ba/41392_2024_1740_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/9bf724f837b1/41392_2024_1740_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/b2750261e556/41392_2024_1740_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/10859382/933b3173f8af/41392_2024_1740_Fig6_HTML.jpg

相似文献

[1]
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.

Signal Transduct Target Ther. 2024-2-12

[2]
PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC.

Sci Rep. 2025-7-14

[3]
TYROBP overexpression alters macrophage phenotype and enhances pancreatic cancer stemness through STAT3 and PKM2 signaling.

Cell Signal. 2025-6-17

[4]
miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.

J Cancer Res Clin Oncol. 2022-8

[5]
eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment.

Cell Death Dis. 2025-7-7

[6]
G3BP2 promotes tumor progression and gemcitabine resistance in PDAC via regulating PDIA3-DKC1-hENT in a stress granules-dependent manner.

Acta Pharmacol Sin. 2025-2

[7]
The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.

J Cancer Res Clin Oncol. 2018-9-22

[8]
M1 Macrophage-Derived TNF-α Promotes Pancreatic Cancer Ferroptosis Via p38 MAPK-ACSL4 Pathway.

Curr Mol Med. 2025-7-10

[9]
Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma.

Mol Ther Oncol. 2024-1-26

[10]
METTL3 depletion blocks vesicular stomatitis virus replication in pancreatic cancer cells through the establishment of an intrinsic antiviral state.

J Virol. 2025-5-20

引用本文的文献

[1]
Noncoding RNAs as regulators of FOSL1 in cancer.

Front Immunol. 2025-8-1

[2]
PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer.

Cancer Res. 2025-9-2

[3]
Death-ision: the link between cellular resilience and cancer resistance to treatments.

Mol Cancer. 2025-5-15

[4]
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation.

J Exp Clin Cancer Res. 2025-3-14

[5]
Transcriptomics Unveil Canonical and Non-Canonical Heat Shock-Induced Pathways in Human Cell Lines.

Int J Mol Sci. 2025-1-26

[6]
Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges.

Curr Oncol Rep. 2025-3

[7]
Insights and therapeutic advances in pancreatic cancer: the role of electron microscopy in decoding the tumor microenvironment.

Front Cell Dev Biol. 2024-12-18

[8]
Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration.

Cancers (Basel). 2024-6-27

[9]
circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).

Mol Cancer. 2024-5-7

本文引用的文献

[1]
Role of Fra-2 in cancer.

Cell Death Differ. 2024-2

[2]
Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28.

Br J Cancer. 2023-8

[3]
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Cancer Commun (Lond). 2023-7

[4]
SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis.

Mol Cancer. 2023-3-17

[5]
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance.

Signal Transduct Target Ther. 2023-1-27

[6]
Hernandezine induces autophagic cell death in human pancreatic cancer cells via activation of the ROS/AMPK signaling pathway.

Acta Pharmacol Sin. 2023-4

[7]
Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm.

Blood. 2022-12-1

[8]
Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.

Cancer Discov. 2022-6-2

[9]
Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma.

Cell Discov. 2022-2-15

[10]
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.

Cancer Res. 2022-2-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索